FDA Moves to Revoke Approval of Controversial Drug Tavneos Amid Data Integrity Concerns
In a significant turn of events, the U.S. Food and Drug Administration (FDA) has announced its intention to withdraw approval for Tavneos, a medication primarily used to treat a rare autoimmune disorder known as ANCA-associated vasculitis. This decision stems from alarming revelations that the data used to secure the drug’s initial approval may have been…
